Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lymphovenous Bypass in the Treatment of Extremity Lymphedema

NCT03683095 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT03683095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lymphovenous Bypass in the Treatment of Extremity Lymphedema
Lead sponsor
Ottawa Hospital Research Institute
Phase
Observational
Overall status
Withdrawn
Start date
April 1, 2023
Completion date
October 1, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymph leakage